Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
Listed Suppliers
0
FDF
0
FDA Orange Book
0
Europe
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 4-methylsalinomycin
2. Narasin A
3. Narasin Monosodium Salt
1. Narasin A
2. Compound 79891
3. Monteban
4. 55134-13-9
5. Antibiotic A-28086 Factor A
6. Antibiotic C 7819b
7. Antibiotic A 28086a
8. Salinomycin, 4-methyl-, (4s)-
9. Lilly 79891
10. 4-methylsalinomycin
11. C-7819b
12. Dzy9vu539p
13. Narasine
14. Narasino
15. Narasinum
16. Compd-79891
17. C 7819b
18. Salinomycin, 4-methyl-, (4s)
19. Monteban (tn)
20. Narasine [inn-french]
21. Narasinum [inn-latin]
22. Narasino [inn-spanish]
23. Narasin (usp/inn)
24. (2r)-2-[(2r,3s,5s,6r)-6-[(2s,3s,4s,6r)-6-[(3s,5s,7r,9s,10s,12r,15r)-3-[(2r,5r,6s)-5-ethyl-5-hydroxy-6-methyloxan-2-yl]-15-hydroxy-3,10,12-trimethyl-4,6,8-trioxadispiro[4.1.57.35]pentadec-13-en-9-yl]-3-hydroxy-4-methyl-5-oxooctan-2-yl]-3,5-dimethyloxan-2-yl]butanoic Acid
25. Unii-dzy9vu539p
26. Brn 1678311
27. Ai3-29798
28. Narasin [usan:usp:inn:ban]
29. Narasin 100 Microg/ml In Acetonitrile
30. Ncgc00167550-01
31. 2h-pyran-2-acetic Acid, Alpha-ethyl-6-(5-(2-(5-ethyltetrahydro-5-hydroxy-6-methyl-2h-pyran-2-yl)-15-hydroxy-2,10,12-trimethyl-1,6,8-trioxadispiro(4.1.5.3)pentadec-13-en-9-yl)-2-hydroxy-1,3-dimethyl-4-oxoheptyl)tetrahydro-3,5-dimethyl-
32. Narasin [usan]
33. Narasin [inn]
34. Narasin [mi]
35. Narasin [mart.]
36. Narasin [usp-rs]
37. Dsstox_cid_26707
38. Dsstox_rid_81840
39. Dsstox_gsid_46707
40. Narasin [green Book]
41. Alpha-ethyl-6-(5-(2-(5-ethyltetrahydro-5-hydroxy-6-methyl-2h-pyran-2-yl)-15-hydroxy-2,10,12-trimethyl-1,6,8-trioxadispiro(4.1.5.3)pentadec-13-en-9-yl)-2-hydroxy-1,3-dimethyl-4-oxoheptyl)tetrahydro-3,5-dimethyl-2h-pyran-2-acetic Acid
42. Schembl123401
43. Narasin [usp Impurity]
44. Chembl2104423
45. Dtxsid2046707
46. Gtpl10835
47. Chebi:183815
48. Tox21_112545
49. Zinc85540282
50. Db11432
51. Ncgc00167550-06
52. Ncgc00167550-08
53. Cas-55134-13-9
54. Hy-121410
55. Cs-0081972
56. D05122
57. Q2104314
58. (2r)-2-[(2r,3s,5s,6r)-6-[(2s,3s,4s,6r)-6-[(3s,5s,7r,9s,10s,12r,15r)-3-[(2r,5r,6s)-5-ethyl-5-hydroxy-6-methyloxan-2-yl]-15-hydroxy-3,10,12-trimethyl-4,6,8-trioxadispiro[4.1.5^{7}.3^{5}]pentadec-13-en-9
Molecular Weight | 765.0 g/mol |
---|---|
Molecular Formula | C43H72O11 |
XLogP3 | 6.2 |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 11 |
Rotatable Bond Count | 12 |
Exact Mass | 764.50746311 g/mol |
Monoisotopic Mass | 764.50746311 g/mol |
Topological Polar Surface Area | 161 Ų |
Heavy Atom Count | 54 |
Formal Charge | 0 |
Complexity | 1360 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 19 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Anti-Bacterial Agents
Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)
Coccidiostats
Agents useful in the treatment or prevention of COCCIDIOSIS in man or animals. (See all compounds classified as Coccidiostats.)
Market Place
Reply
03 Sep 2024
Reply
20 Aug 2021
Reply
30 May 2018
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Narasin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Narasin, including repackagers and relabelers. The FDA regulates Narasin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Narasin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Narasin supplier is an individual or a company that provides Narasin active pharmaceutical ingredient (API) or Narasin finished formulations upon request. The Narasin suppliers may include Narasin API manufacturers, exporters, distributors and traders.
Narasin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Narasin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Narasin GMP manufacturer or Narasin GMP API supplier for your needs.
A Narasin CoA (Certificate of Analysis) is a formal document that attests to Narasin's compliance with Narasin specifications and serves as a tool for batch-level quality control.
Narasin CoA mostly includes findings from lab analyses of a specific batch. For each Narasin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Narasin may be tested according to a variety of international standards, such as European Pharmacopoeia (Narasin EP), Narasin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Narasin USP).
LOOKING FOR A SUPPLIER?